Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Difficult Decisions in Thoracic Surgery : An Evidence-Based Approach / / edited by Mark K. Ferguson
| Difficult Decisions in Thoracic Surgery : An Evidence-Based Approach / / edited by Mark K. Ferguson |
| Edizione | [4th ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (XV, 705 p. 19 illus., 17 illus. in color.) |
| Disciplina | 617.54 |
| Collana | Difficult Decisions in Surgery: An Evidence-Based Approach |
| Soggetto topico |
Thoracic surgery
Surgery Thoracic Surgery General Surgery Cirurgia toràcica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-47404-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Introduction -- 2. Evidence based medicine: levels of evidence and evaluation systems -- 3. Decision analytic techniques and other decision processes -- 4. Decision making - the surgeon's perspective -- 5. Decision making - the patient's perspective -- 6. EBUS vs mediastinoscopy for initial pathologic mediastinal staging in NSCLC -- 7. Is preoperative smoking cessation for lung resection patients effective in reducing surgical morbidity -- 8. Is low tech as good as high tech exercise testing in assessing healthy candidates for lung resection -- 9. Does assessment of frailty and sarcopenia in lung resection candidates affect oatient selection -- 10. Can frailty and sarcopenia be mitigated in lung resection candidates -- 11. Is antibiotic prophylaxis necessary for major lung resection -- 12. Uniportal vs multiportal VATS lobectomy -- 13. Robotic vs VATS for major lung resection -- 14. Does intrapleural therapy for persistent postoperative air leak reduce air leak duration -- 15. Segmentectomy vs lobectomy in patients with good pulmonary function -- 16. Is resection of persistent N2 disease after induction therapy effective -- 17. N2 disease discovered at the time of lung resection - resect or abort? -- 18. Is lung resection safe after immunotherapy -- 19. Is an enhanced recovery programs for lobectomy patients effective in improving surgical outcomes -- 20. Resection vs SBRT for stage I NSCLC in patients with good pulmonary function -- 21. Do endobronchial valves assist in resolution of postoperative persistent air leak -- 22. Is long-term surveillance effective after resection of stage I NSCLC -- 23. Does ECMO for lung failure in ICU patients improve survival -- 24. Does resection of oligometastatic disease in lung cancer patients improve survival -- 25. Is pulmonary metastasectomy effective in prolonging survival -- 26. Resection vs endoscopic therapy for T1bN0 esophageal adenocarcinoma -- 27. Does induction therapy for T2N0 esophageal adenocarcinoma improve survival -- 28. Do enhanced recovery programs for esophagectomy patients improve outcomes -- 29. Does jejunostomy after esophagectomy improve outcomes -- 30. Surgery vs definitive chemoradiotherapy for regionally advanced esophageal squamous cell cancer -- 31. Open vs robotic resection for esophageal adenocarcinoma -- 32. Two-field vs three-field lymphadenectomy for esophageal adenocarcinoma -- 33. Is resection of more nodes better for treating esophageal cancer -- 34. Salvage esophagectomy for persistent disease after definitive chemoradiotherapy -- 35. Early postoperative feeding after esophagectomy -- 36. Stent vs primary repair for esophageal perforation -- 37. Sump therapy vs stenting for esophageal anastomotic leak -- 38. Thoracoscopic vs endoscopic therapy for small submucosal esophageal tumors -- 39. Laparoscopic vs endoscopic therapy for achalasia -- 40. Laparoscopy or endoscopic therapy for recurrent symptoms from achalasia -- 41. Laparoscopy or thoracotomy for symptomatic recurrent paraesophageal hernia -- 42. Does diaphragm pacing for bilateral phrenic nerve paralysis improve function or quality of life -- 43. Does phrenic nerve reconstruction for unilateral diaphragm paralysis improve function or quality of life -- 44. Is plication for diaphragmatic eventration effective in improving function -- 45. Is temporary transvenous pacing effective in ventilator weaning -- 46. Does temporary diaphragm paralysis aid in eliminanting residual pleural space after lung resection -- 47. Is long-term stenting for benign airway obstruction effective -- 48. Are engineered tissues useful for tracheal reconstruction -- 49. Are positive margins acceptable in resection for low grade malignancies -- 50. Optimal management of posttransplant brochial stenosis - stenting or reoperation -- 51. Is tPA/Dnase therapy effective for managing pleural empyema -- 52. VATS vs open management of pleural empyema -- 53. Indewlling catheter vs chemical pleurodesis for symptomatic malignant pleural effusion -- 54. Extended pleurectomy sparing the diaphragm for malignant pleural mesothelioma -- 55. Quality of life: EPD vs EPP -- 56. Does thymectomy improve outcomes for myasthenia gravis -- 57. MRI for evaluation of suspected encapsulated thymoma -- 58. Lobectomy vs thymectomy for encapsulated thymoma -- 59. Robotic vs VATS thymectomy for thymoma -- 60. Resection of mediastinal parathyroid adenomas -- 61. Thymectomy in the setting of pleural metastases -- 62. Sympathectomy for malignant ventricular arrhythmias -- 63. Extent of surgery for palmar hyperhidrosis -- 64. Synthetic vs biologic reconstruction of bony chest wall defects -- 65. Traumatic rib fracture: conservative therapy or surgical fixation? -- 66. Is surgical management of flail chest effective -- 67. Epidural vs regional blocks for VATS and thoracotomy -- 68. Pectus deformities in adults - when is surgery indicated? -- 69. Pectus deformities in adults - Nuss bar vs open repair. |
| Record Nr. | UNINA-9910411945803321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Difficult Decisions in Thoracic Surgery : An Evidence-Based Approach / / edited by Mark K. Ferguson
| Difficult Decisions in Thoracic Surgery : An Evidence-Based Approach / / edited by Mark K. Ferguson |
| Edizione | [3rd ed. 2014.] |
| Pubbl/distr/stampa | London : , : Springer London : , : Imprint : Springer, , 2014 |
| Descrizione fisica | 1 online resource (766 p.) |
| Disciplina | 617 |
| Collana | Difficult Decisions in Surgery: An Evidence-Based Approach |
| Soggetto topico |
Thoracic surgery
Surgery Thoracic Surgery General Surgery |
| ISBN | 1-4471-6404-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Introduction -- Part 1. Evaluations and Decisions -- 2. Evidence based medicine: quality of evidence and evaluation systems -- 3. Decision analytic techniques and other decision processes -- 4. Decision making: the surgeon's perspective -- 5. Decision making: the patient's perspective -- Part 2. Lung.- 6. Indications for pretreatment pathologic mediastinal staging in Non-small Cell Lung Cancer (NSCLC) -- 7. Preoperative Smoking Cessation for Lung Resection Patients -- 8. High tech exercise testing in assessing candidates for lung resection -- 9. Management of perioperative anticoagulation during lung resection -- 10. Perioperative arrhythmia prophylaxis for major lung resection -- 11. VATS vs open lobectomy for stage I or II NSCLC -- 12. Robotic-assisted thoracoscopic surgery (RATS) versus video-assisted thoracoscopic surgery (VATS) lobectomy for Stage I or II non-small cell lung cancer (NSCLC) -- 13. Lobectomy after induction therapy for non-small cell lung cancer in the presence of persistent N2 disease -- 14. Pneumonectomy after induction therapy for non-small cell lung cancer -- 15. Resection vs SBRT for stage I NSCLC in patients with good pulmonary function -- 16. Digital drainage systems after major lung resection -- 17. Management of Persistent Post-operative Alveolar Air Leak -- 18. Surveillance after resection of stage I non small cell lung cancer -- 19. Support therapy for lung failure: The utility of device therapy -- 20. Extracorporeal support for lung grafts prior to transplantation -- 21. Pulmonary Metastasectomy -- Part 3. Esophagus -- 22. Optimal therapy for Barrett High Grade Dysplasia -- 23. Preoperative chemo versus chemoradiotherapy for regionally advanced esophageal adenocarcinoma -- 24. The role of surgery in the management of regionally advanced esophageal squamous cell cancer -- 25. Optimal surgical approach to esophagectomy for distal esophageal adenocarcinoma -- 26. Regional extent of lymphadenectomy for esophageal cancer -- 27. Optimal number of lymph nodes to resect for esophageal cancer -- 28. Salvage esophagectomy for persistent disease after definitive chemoradiotherapy -- 29. Gastric emptying procedure after esophagectomy -- 30. Postoperative adjuvant therapy after resection of regionally advanced esophageal cancer -- 31. Prophylactic antireflux surgery in lung transplantation -- 32. Surgical versus Endoscopic Management for esophageal perforations -- 33. Stent for esophageal anastomotic leak -- 34. Management of small esophageal GIST tumors -- 35. Surgery for minimally symptomatic pulsion diverticula of the thoracic esophagus -- 36. Partial versus total fundoplication for GERD in patients with normal esophageal motility -- Part 4. Diaphragm -- 37. Diaphragm pacing for paralysis -- 38. Minimally invasive versus open repair of giant paraesophageal hernia -- 39. Synthetic reinforcement of diaphragm closure for large hiatal hernia repair -- 40. Diaphragmatic plication for eventration -- 41. Management of recurrent minimally symptomatic paraesophageal hernia -- Part 5. Airway -- 42. Stenting for benign airway obstruction -- 43. Bioengineered tissues for tracheal reconstruction -- 44. Percutaneous versus standard tracheostomy in the critically ill adult -- 45. Carinal resection for Non Small Cell Lung Cancer -- Part 6. Pleura and Pleural Spaces -- 46. Management of Persistent Postoperative Air Leaks -- 47. Fibrinolytics for managing pleural empyema -- 48. VATS versus open management of pleural empyema -- 49. Optimal management of symptomatic malignant pleural effusion -- 50. Pleurectomy versus radical pleuropneumonectomy for malignant pleural mesothelioma -- 51. Surgery and medical therapy for malignant pleural mesothelioma -- Part 7. Mediastinum -- 52. Extended versus standard thymectomy for myasthenia gravis -- 53. Optimal approach for resection of encapsulated thymoma: open versus VATS -- 54. Robotic versus VATS thymectomy for encapsulated thymoma -- 55. Video mediastinoscopy versus standard mediastinoscopy -- 56. Debulking for extensive thymoma -- 57. Surgery for palmar hyperhidrosis: patient selection and extent of surgery -- Part 8. Chest Wall -- 58. Synthetic versus biologic reconstruction of bony chest wall defects -- 59. Management of flail chest -- 60. Management of pectus deformities in adults. |
| Record Nr. | UNINA-9910300340203321 |
| London : , : Springer London : , : Imprint : Springer, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||